Literature DB >> 7760821

Direct transcriptional repression by pRB and its reversal by specific cyclins.

R Bremner1, B L Cohen, M Sopta, P A Hamel, C J Ingles, B L Gallie, R A Phillips.   

Abstract

It was recently shown that the E2F-pRB complex is a negative transcriptional regulator. However, it was not determined whether the whole complex or pRB alone is required for repression. Here we show that pRB and the related protein p107 are capable of direct transcriptional repression independent of E2F. When fused to the DNA binding domain of GAL4, pRB or p107 represses transcription of promoters with GAL4 binding sites. Thus, E2F acts as a tether for pRB or p107 but is not actively involved in repression of other enhancers. This function of pRB maps to the pocket and is abrogated by mutation of this domain. This result suggests an intriguing model in which the pocket has a dual function, first to bind E2F and second to repress transcription directly, possibly through interaction with other proteins. We also show that direct transcriptional repression by pRB is regulated by phosphorylation. Mutations which render pRB constitutively hypophosphorylated potentiate repression, while phosphorylation induced by cyclin A or E reduces repression ninefold.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7760821      PMCID: PMC230558          DOI: 10.1128/MCB.15.6.3256

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  73 in total

1.  DNA topoisomerase I is involved in both repression and activation of transcription.

Authors:  A Merino; K R Madden; W S Lane; J J Champoux; D Reinberg
Journal:  Nature       Date:  1993-09-16       Impact factor: 49.962

2.  Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.

Authors:  L Zhu; S van den Heuvel; K Helin; A Fattaey; M Ewen; D Livingston; N Dyson; E Harlow
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

Review 3.  Unraveling the function of the retinoblastoma gene.

Authors:  E Zacksenhaus; R Bremner; Z Jiang; R M Gill; M Muncaster; M Sopta; R A Phillips; B L Gallie
Journal:  Adv Cancer Res       Date:  1993       Impact factor: 6.242

4.  E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.

Authors:  E K Flemington; S H Speck; W G Kaelin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

5.  Physical interaction of the retinoblastoma protein with human D cyclins.

Authors:  S F Dowdy; P W Hinds; K Louie; S I Reed; A Arnold; R A Weinberg
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

6.  Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein.

Authors:  C Y Wang; B Petryniak; C B Thompson; W G Kaelin; J M Leiden
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

7.  Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain.

Authors:  X Mayol; X Graña; A Baldi; N Sang; Q Hu; A Giordano
Journal:  Oncogene       Date:  1993-09       Impact factor: 9.867

8.  Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.

Authors:  J Kato; H Matsushime; S W Hiebert; M E Ewen; C J Sherr
Journal:  Genes Dev       Date:  1993-03       Impact factor: 11.361

9.  A retinoblastoma-binding protein related to a negative regulator of Ras in yeast.

Authors:  Y W Qian; Y C Wang; R E Hollingsworth; D Jones; N Ling; E Y Lee
Journal:  Nature       Date:  1993-08-12       Impact factor: 49.962

10.  New eukaryotic transcriptional repressors.

Authors:  S Saha; J M Brickman; N Lehming; M Ptashne
Journal:  Nature       Date:  1993-06-17       Impact factor: 49.962

View more
  64 in total

1.  A mechanism for Rb/p130-mediated transcription repression involving recruitment of the CtBP corepressor.

Authors:  A R Meloni; E J Smith; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Active repression and E2F inhibition by pRB are biochemically distinguishable.

Authors:  J F Ross; A Näär; H Cam; R Gregory; B D Dynlacht
Journal:  Genes Dev       Date:  2001-02-15       Impact factor: 11.361

3.  Structural basis of DNA recognition by the heterodimeric cell cycle transcription factor E2F-DP.

Authors:  N Zheng; E Fraenkel; C O Pabo; N P Pavletich
Journal:  Genes Dev       Date:  1999-03-15       Impact factor: 11.361

4.  Cumulative effect of phosphorylation of pRB on regulation of E2F activity.

Authors:  V D Brown; R A Phillips; B L Gallie
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

5.  Histone deacetylase-dependent transcriptional repression by pRB in yeast occurs independently of interaction through the LXCXE binding cleft.

Authors:  B K Kennedy; O W Liu; F A Dick; N Dyson; E Harlow; M Vidal
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

Review 6.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

7.  Retinoblastoma tumor suppressor protein signals through inhibition of cyclin-dependent kinase 2 activity to disrupt PCNA function in S phase.

Authors:  Z Sever-Chroneos; S P Angus; A F Fribourg; H Wan; I Todorov; K E Knudsen; E S Knudsen
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

8.  Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals.

Authors:  R Sears; K Ohtani; J R Nevins
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

9.  RB and hbrm cooperate to repress the activation functions of E2F1.

Authors:  D Trouche; C Le Chalony; C Muchardt; M Yaniv; T Kouzarides
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

10.  Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130.

Authors:  Jan-Hermen Dannenberg; Leontine Schuijff; Marleen Dekker; Martin van der Valk; Hein te Riele
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.